The latest financial statement is for the year ending 2026-01-31.
| Cash Flow | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 |
|---|---|---|---|---|
| Net loss (including amounts attributable to redeemable non-controlling interests) | -130,786 | -104,047 | -130,429 | -140,746 |
| Stock-based compensation | 143,738 | 115,140 | 97,232 | 72,243 |
| Amortization of deferred contract costs | 41,267 | 35,014 | 29,788 | 23,639 |
| Depreciation and amortization | 19,328 | 10,115 | 6,963 | 4,618 |
| Provision for credit losses | 666 | 2,331 | 2,020 | 807 |
| Value of common stock donated to charity | 3,223 | 3,776 | 3,762 | 4,260 |
| Accretion of discount on marketable securities | -951 | -2,079 | -2,077 | 1,336 |
| Non-cash foreign exchange (gain) loss | 73 | 1,033 | -460 | -1,612 |
| Fair value adjustments to contingent consideration | 0 | 223 | 1,572 | - |
| Fixed asset write offs | 80 | 488 | - | - |
| Other | 144 | 152 | 349 | -495 |
| Accounts receivable | 22,715 | 5,363 | 14,008 | 14,650 |
| Prepaid expenses and other current assets | -3,569 | 6,629 | 3,413 | -3,596 |
| Deferred contract costs | 65,249 | 48,171 | 45,119 | 30,469 |
| Rou assets and liabilities | 1,133 | -1,939 | -4,275 | -3,355 |
| Other assets | 1,880 | 29 | -229 | -1,711 |
| Accounts payable | -601 | -3,912 | 3,419 | 906 |
| Accrued expenses and other current liabilities | 26,191 | 3,694 | 20,990 | 5,075 |
| Deferred revenue | 57,137 | 35,887 | 34,108 | 39,894 |
| Other long-term liabilities | -229 | -66 | 571 | 10 |
| Net cash provided by operating activities | 71,438 | 36,680 | 6,850 | -22,308 |
| Cash paid for acquisition, net of cash acquired | 181,854 | 0 | 16,319 | - |
| Purchases of property and equipment | 9,588 | 13,234 | 9,761 | 15,447 |
| Capitalized internal-use software costs | 3,776 | 3,814 | 3,574 | 1,258 |
| Purchases of marketable securities | 151,641 | 217,975 | 248,059 | 638,221 |
| Maturities of marketable securities | 175,208 | 195,353 | 257,737 | 256,407 |
| Return of principal on marketable securities | 120,744 | 3,200 | - | - |
| Net cash used in investing activities | -50,907 | -36,470 | -19,976 | -398,519 |
| Proceeds from issuance of common stock upon initial public offering, net of offering costs | - | - | 0 | 0 |
| Investment from redeemable non-controlling interest | - | - | 0 | 0 |
| Proceeds from exercise of common stock options | 15,861 | 6,906 | 7,263 | 11,332 |
| Proceeds from stock associated with employee stock purchase plan | 7,099 | 7,705 | 6,011 | - |
| Payments Of Stock Issuance Costs | - | - | 0 | 0 |
| Payment of deferred offering costs | - | - | 165 | 0 |
| Repurchase of shares related to early exercised options | - | - | 0 | 0 |
| Payments of deferred purchase consideration | 0 | 2,916 | - | - |
| Net cash provided by financing activities | 22,960 | 11,695 | 13,109 | 11,332 |
| Effect of foreign currency exchange rate changes on cash, cash equivalents, and restricted cash | 1,255 | -444 | -475 | -855 |
| Net change in cash, cash equivalents, and restricted cash | 44,746 | 11,461 | -492 | -410,350 |
| Cash, cash equivalents, and restricted cash, beginning of period | 83,592 | 72,131 | 72,623 | 482,973 |
| Cash, cash equivalents, and restricted cash, end of period | 128,338 | 83,592 | 72,131 | 72,623 |
Braze, Inc. (BRZE)
Braze, Inc. (BRZE)